Hyperphosphatemia is associated with patency loss of arteriovenous fistula after 1 year of hemodialysis.

about

A meta-analysis of the association between diabetic patients and AVF failure in dialysis.

P2860

Q55399912-FEDB9859-EE9B-4E58-90FB-921562DD9FC2

P2860

Hyperphosphatemia is associated with patency loss of arteriovenous fistula after 1 year of hemodialysis.

Item

http://www.wikidata.org/entity/Q36061887

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Hyperphosphatemia is associate ...... after 1 year of hemodialysis.

@ast

Hyperphosphatemia is associate ...... after 1 year of hemodialysis.

@en

type

Item

label

Hyperphosphatemia is associate ...... after 1 year of hemodialysis.

@ast

Hyperphosphatemia is associate ...... after 1 year of hemodialysis.

@en

prefLabel

Hyperphosphatemia is associate ...... after 1 year of hemodialysis.

@ast

Hyperphosphatemia is associate ...... after 1 year of hemodialysis.

@en

P1476

Hyperphosphatemia is associate ...... after 1 year of hemodialysis.

@en

P2093

Chun-Gyoo Ihm

http://www.w3.org/2001/XMLSchema#string

Hyae Min Lee

http://www.w3.org/2001/XMLSchema#string

Ju-Young Moon

http://www.w3.org/2001/XMLSchema#string

Sang-Ho Lee

http://www.w3.org/2001/XMLSchema#string

Sug-Gyun Shin

http://www.w3.org/2001/XMLSchema#string

Tae-Won Lee

http://www.w3.org/2001/XMLSchema#string

Young-Il Jo

http://www.w3.org/2001/XMLSchema#string

P2860

The role of phosphorus in the development and progression of vascular calcification

The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology.

Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management.

Risk factors associated with patency loss of hemodialysis vascular access within 6 months

Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro.

Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative

Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial.

The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients.

Higher impact of mineral metabolism on cardiovascular mortality in a European hemodialysis population.

The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis.

P304

41-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.KRCP.2015.02.001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sang-Woong Han

P577

2015-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272753438

http://www.w3.org/2001/XMLSchema#string

P698

26484018

http://www.w3.org/2001/XMLSchema#string

P932

4570653

http://www.w3.org/2001/XMLSchema#string

Hyperphosphatemia is associated with patency loss of arteriovenous fistula after 1 year of hemodialysis.

about

P2860

P2860

Hyperphosphatemia is associated with patency loss of arteriovenous fistula after 1 year of hemodialysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932